Extraneal Injection, Solution
Product Images NDC 0941-0679

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Extraneal (NDC 0941-0679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vantive Us Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Structural Formula Of Icodextrin (Image 01)

Image Of Structural Formula Of Icodextrin (Image 01)
Chemical structure diagram of the active ingredient icodextrin from the prescription drug EXTRANEAL, showing its polysaccharide molecular components and bonds.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A set of three bar graphs comparing baseline values to values at Week 2 and Week 4 for two groups labeled as Receiving 80% Dose and Baseline. The variables shown include Mean Arterial Pressure (MAP), Cardiac Output (CO), and Systemic Vascular Resistance (SVR). Significant differences are indicated with asterisks. The graphs display changes over time with labeled axes and error bars.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A set of four bar graphs comparing data at Baseline, Week 1, and Week 2 for two groups labeled as 4.25% Dextrose and Extraneal. Each graph measures different variables related to treatment effects over time, with statistical significance indicated by asterisks between groups.*
FDA Label Image

Extraneal Representative Container Label Ndc 0941-0679-06 (Image 04)

Extraneal Representative Container Label  Ndc 0941-0679-06 (Image 04)
Label for EXTRANEAL (icodextrin) Peritoneal Dialysis Solution injection, solution for intraperitoneal administration. Contains 7.5 g/100 mL icodextrin, and sodium chloride, sodium lactate, calcium chloride, magnesium chloride in specified amounts per 100 mL. Packaged by Baxter Healthcare Corporation in a 2000 mL Ambu-Flex II plastic container. Instructions and caution statements about storage, administration, and sterility are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.